No CrossRef data available.
Article contents
Risk factors for healthcare-associated infection among patients hospitalized with COVID-19 infection
Published online by Cambridge University Press: 25 November 2024
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

- Type
- Research Brief
- Information
- Copyright
- © HCA Healthcare, 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
Alvarez, CR, Dudeck, MA, Kofman, A, et al. Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2023;44:997–1001.Google Scholar
Baker, MA, Sands, KE, Huang, SS, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections. Clin Infect Dis 2022;74:1748–1754.CrossRefGoogle ScholarPubMed
Weiner-Lastinger, LM, Pattabiraman, V, Konnor, RY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2022;43:12–25.CrossRefGoogle Scholar
Ben-Aderet, MA, Madhusudhan, MS, Haroun, P, et al. Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line-associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic. Infect Control Hosp Epidemiol 2023;44:1108–1115.CrossRefGoogle ScholarPubMed
Fakih, MG, Bufalino, A, Sturm, L, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol 2022;43:26–31.CrossRefGoogle ScholarPubMed
Sands, KE, Blanchard, EJ, Fraker, S, Korwek, K, Cuffe, M. Health care–associated infections among hospitalized patients with COVID-19, March 2020-March 2022. JAMA Network Open 2023;6:e238059.CrossRefGoogle ScholarPubMed
National Institutes of Health. Systemic Corticosteroids. 2023. https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/systemic-corticosteroids/. Accessed December 19, 2023.Google Scholar
RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2023;401:1499–1507.CrossRefGoogle Scholar
Bakullari, A, Metersky, ML, Wang, Y, et al. Racial and ethnic disparities in healthcare-associated infections in the United States, 2009-2011. Infect Control Hosp Epidemiol 2014;35:S10–16.CrossRefGoogle ScholarPubMed
Gualandi, N, Mu, Y, Bamberg, WM, et al. Racial disparities in invasive Methicillin-resistant Staphylococcus aureus infections, 2005-2014. Clin Infect Dis 2018;67:1175–1181.CrossRefGoogle ScholarPubMed